JOHNSON INVESTMENT COUNSEL INC

Position in JAZZ — Jazz Pharmaceuticals plc

CIK 821197 Cincinnati, OH

Position in JAZZ

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$2,361,987

-$961,701 QoQ

Shares Held

9,802

-44.2% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#41

of 178 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 13% Shared 0% None 87%

Healthcare · as of Jun 30, 2026

JOHNSON INVESTMENT COUNSEL INC holds $10,648,095 across 9 Biotechnology names. JAZZ ranks #3 (22.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	7,360	$3,655,932
2	HALO	Halozyme Therapeutics, Inc.	37,016	$2,897,242
3	JAZZ	Jazz Pharmaceuticals plc This page	9,802	$2,361,987
4	INCY	Incyte Corp	4,681	$530,638
5	TGTX	Tg Therapeutics, Inc.	8,212	$451,167
6	ARWR	Arrowhead Pharmaceuticals, Inc.	4,000	$326,040
7	REGN	Regeneron Pharmaceuticals, Inc.	468	$291,816
8	AVIR	Atea Pharmaceuticals, Inc.	25,590	$118,993

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,361,987	9,802	-44.2%	Shares	Sole	2026-07-23
2026-03-31	$3,323,688	17,581	+0.5%	Shares	Sole	2026-05-04
2025-12-31	$2,973,980	17,494	-17.3%	Shares	Sole	2026-02-13
2025-09-30	$2,788,097	21,154	+1.5%	Shares	Sole	2025-11-06
2025-06-30	$2,211,010	20,835	+0.2%	Shares	Sole	2025-07-25
2025-03-31	$2,581,078	20,790	+5.1%	Shares	Sole	2025-04-21
2024-12-31	$2,437,138	19,790	-5.3%	Shares	Sole	2025-02-07
2024-09-30	$2,327,354	20,890	+0.8%	Shares	Sole	2024-11-04
2024-06-30	$2,212,512	20,730	+23.1%	Shares	Sole	2024-08-08
2024-03-31	$2,027,872	16,840	+35.9%	Shares	Sole	2024-05-09
2023-12-31	$1,524,708	12,396	-5.3%	Shares	Sole	2024-02-07
2023-09-30	$1,695,146	13,096	+0.8%	Shares	Sole	2023-11-13
2023-06-30	$1,609,874	12,986	+25.6%	Shares	Sole	2023-08-10
2023-03-31	$1,513,052	10,340	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.